Usefulness of procalcitonin upon admission to intensive care in the diagnosis and prognosis of sepsis;Valor de la procalcitonina al ingreso en terapia intensiva para el diagnóstico y el pronóstico de la sepsis

Medicina Intensiva

Volumn 37, Issue 3, 2013, Pages 156-162

  Moretti, D ^a   Ramirez M M ^a   Settecase, C J ^a   Bagilet, D H ^a   Quaglino, M B ^b  

^a Hospital Eva Peron   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

C reactive protein; Procalcitonin; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEPSIS; SURVIVOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNIVERSITY HOSPITAL;

ADULT; CALCITONIN; FEMALE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84876710687     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2012.03.018     Document Type: Article

References (39)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Cavaillon JM and Adrie C. Sepsis and Non-infectious Systemic Inflammation. Weinheim;WILEY-VCH: 2009.
3. Meisner M. Procalcitonin (PCT): a new, innovative infection parameter. Biochemical and clinical aspects 2000, Thieme, Stuttgart, New York.
4. Jones A.E., Fiechtl J.F., Brown M.D., Ballew J.J., Kline J.A. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50:34-41.
5. Tang B.M., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.
6. Uzzan B., Cohen R., Nicolas P., Cucherat M., Perret G.Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003.
7. Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26(Suppl.):S148-S152.
8. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin- 8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
9. Muller B., Becker K.L., Schachinger H., Rickenbacher P.R., Huber P.R., Zimmerli W., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28:977-983.
10. Suprin E., Camus C., Gacouin A., Le Tulzo Y., Lavoue S., Feuillu A., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000, 26:1232-1238.
11. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
12. Torrabadella de Reynoso P., Salgado Remigio A. Tratamiento de la sepsis grave y el shock séptico, el futuro ha empezado. Med Intensiva 2001, 25:62-65.
13. León Gil C., García-Castrillo Riesgo L., Moya Mir M., Artigas Raventós A., Borges Sa M., Candel González F.J., et al. Documento de Consenso (SEMES-SEMICYUC). Recomendaciones del manejo diagnóstico-terapéutico inicial y multidisciplinario de la sepsis grave en los Servicios de Urgencias hospitalarios. Med Intensiva 2007, 31:375-387.
14. International guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008, 34:17-60. Surviving Sepsis Campaign.
15. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
16. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15.
17. Povoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2004, 11:101-108.
18. Yentis S.M., Soni N., Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995, 21:602-605.
19. Matson A., Soni N., Sheldon J. C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care 1991, 19:182-186.
20. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31:1737-1741.
21. Lobo S.M., Lobo F.R., Bota D.P., Lopes-Ferreira F., Soliman H.M., Melot C., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049.
22. Prieto M.F., Kilstein J., Bagilet D., Pezzotto C. Proteína reactiva como factor pronóstico de mortalidad en la unidad de cuidados intensivos. Med Intensiva 2008, 9:424-430.
23. Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infec Dis 2004, 39:206-217.
24. Gómez Gerique J.A., Espejo M.O., Torrealba Rodríguez M.I., Alvarez J.G., Castellanos-Ortega A., Suberviola B., et al. Evaluación de la capacidad diagnóstica y pronóstica de procalcitonina, proteína C reactiva, interleucina-6 y proteína ligadora de lipopolisacáridos en pacientes con sospecha de sepsis. Rev Lab Clin 2010, 1:12-19.
25. Ugarte H., Silva E., Mercan D., de Mendonca A., Vincent J.L. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27:498-504.
26. Mimoz O., Benoist J.F., Edouard A.R., Assicot M., Bohuon C., Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998, 24:185-188.
27. Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998, 24:680-684.
28. Hensel M., Volk T., Docke W.D., Kern F., Tschirna D., Egerer K., et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998, 89:93-104.
29. Zeni F., Viallon A., Assicot M., Tardy B., Vindimian M., Page Y., et al. Procalcitonin serum concentrations and severity of sepsis. Clin Intens Care 1994, 5(Suppl. 2):89-98.
30. Liaudat S., Dayer E., Praz G., Bille J., Troillet N. Usefulness of procalcitonina serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20:524-527.
31. Cueto G., Torres-Boden M., Vetere L., Santos C., Castarataro C., Pimentel R., et al. Validación del APACHE II y SAPS II en la República Argentina. Med Intensiva 2002, 19:17-28.
32. Jensen J.U., Heslet L., Jensen T.H., Espersen K., Steffensen P., Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34:2596-2602.
33. Clec'h C., Ferriere F., Karoubi P., Fosse J.P., Cupa M., Hoang P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004, 32:1166-1169.
34. Oberhoffer M., Vogelsang H., Russwurm S., et al. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999, 37:363-368.
35. Ruiz-Alvarez M.J., García-Valdecasas S., De Pablo R., Sanchez-García M., Coca C., Groeneveld T.W. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009, 24:63-71.
36. Meisner M., Tschaikowsky K., Palmaers T., Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999, 3:45-50.
37. Dahaba A.A., Hagara B., Fall A., Rehak P.H., List W.F., Metzler H. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006, 97:503-508.
38. Karlsson S., Heikkinen M., Pettilä V., Alila S., Väisänen S., Pulkki K., et al. Finnsepsis Study Group: Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Critical Care 2010, 14:R205.
39. Suberviola B., Castellanos-Ortega A., González-Castro A., García-Astudillo L.A., Fernández-Mire B. Valor pronóstico del aclaramiento de procalcitonina. PCR y leucocitos en el shock séptico. Med Intensiva 2012, 36:177-184.